The new menu addition comes as part of the pizza chain’s efforts to innovate and expand its product offerings. The ...
Investing.com -- Tesla (NASDAQ: TSLA )’s sales in Scandinavia have seen a sharp decline in February compared to the same period last year, impacting its market share as the electric vehicle producer ...
UBS analysts believe that despite recent market volatility, the U.S. equity bull market remains intact, with historically low ...
Brasil (NYSE: VIV) has received an upgrade from Barclays (LON: BARC), reflecting strong financial trends and potential growth stemming from ...
Shares of Lexicon Pharmaceuticals , Inc. (Nasdaq: NASDAQ: LXRX) plummeted 50% following the announcement of topline results from its Phase 2b PROGRESS study, which evaluated the efficacy of ...
Equity positioning in the U.S. stock market has sharply declined last week, returning to near-neutral levels following ...
Tether has already established a benchmark for stablecoin transparency through its quarterly attestations with BDO, one of the top five leading global independent accounting firms. The full audit will ...
Wedbush analysts see upside for Palantir Technologies (NASDAQ:PLTR) as the evolving spending environment in Washington, D.C., ...
Investing.com -- Man Group (LON: EMG) has been downgraded to "neutral" from a "buy" rating by BofA Securities, following a ...
As Rabobank economists note, the ECB likely sealed its new macroeconomic projections when gas prices were at a peak in the ...
Investing.com -- Apple’s partnership with Alibaba Group Holding Ltd (HK: 9988) (NYSE: BABA) is key for the US technology ...
Investing.com -- Shares of Lexicon Pharmaceuticals , Inc. (NASDAQ: LXRX) tumbled 55% after the company announced topline results from its PROGRESS Phase 2b study, which evaluated pilavapadin in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results